The direct cardioprotective effects of GLP-1 RAs encompass the reduction of inflammation, the lowering of oxidative stress, the decrease of fibrosis, the regulation of lipids, and the preservation of mitochondrial function
A doctor or another healthcare professional should monitor your kidney health during Ozempic treatment
It is also used for withdrawal from alcohol, Down syndrome, bipolar disorder, poor circulation in the brain after a stroke, cataracts, nerve pain due to diabetes, nerve pain due to drugs used in the treatment of AIDS or cancer, nerve pain caused by sciatica, fibromyalgia, and facial paralysis
Why do surgeons care about GLP-1 medications like semaglutide
) Cardiovascular symptoms rapid heart rate chest pain palpitations shortness of breath Severe allergic reactions swelling of face, lips, or throat difficulty breathing widespread rash or hives Severe abdominal pain, vomiting, or signs of dehydration These may reflect toxicity or contamination of the product
Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
